US link-up to develop tissue regeneration products:
This article was originally published in Clinica
Executive Summary
Osiris Therapeutics and California-based Activated Cell Therapy have agreed to develop structural and connective tissue regeneration products. Osiris will have exclusive rights to use Activated Cell Therapy's cell isolation and enrichment technology for the recovery of mesenchymal stem cells. Osiris, based in Baltimore, Maryland, intends to use the stem cells to develop cell therapy products to treat diseased or damaged structural and connective tissues.